你好! Shipping to Taiwan with premium packaging for just NT$300 

Ship to
Taiwan
0

My Account

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menu

Select your country

Americas

Europe

Rest of the world

portada Cytokine-Based Immunotherapy Part B: Volume 401
Type
Physical Book
Publisher
Author
Language
English
Pages
277
Format
Hardcover
ISBN13
9780443417610

Cytokine-Based Immunotherapy Part B: Volume 401

Galluzzi, Lorenzo; Aranda Vega, Fernando; Berraondo, Pedro (Author) · Academic Press · Hardcover

Cytokine-Based Immunotherapy Part B: Volume 401 - Galluzzi, Lorenzo; Aranda Vega, Fernando; Berraondo, Pedro

New Book Imported to Taiwan
Delivery: 15 Sep - 24 Sep Shipping: 11 to 13 business days.
NT$ 6,831
NT$ 6,831

Choose the list to add your product or create one New List

Go to My Wishlists
Calculate shipping cost

Synopsis "Cytokine-Based Immunotherapy Part B: Volume 401"

Cytokine-Based immunotherapy: Part B, Volume 401 delves into the intricate world of cytokines, vital signaling proteins that orchestrate the immune response and their pivotal role in modulating various immune functions. From their fundamental mechanisms to their therapeutic applications, this book offers a thorough examination of the latest trends and developments in leveraging cytokines for immunotherapy. Chapters cover Cytokine-based immunotherapy in pancreatic cancer, IL-33 and its pleiotropic role in cancer, Immunocytokines based on IL-12 for cancer therapy: enhancing efficacy and reducing toxicity, Cytokine network in immunosuppression and tumor development in glioblastoma, The Double-Edged Role of Interferon Gamma in Cancer Immunity, and much more. An additional section covers Engineering Interleukin-10 for Therapeutic Applications, IL-23 Blockade: A Strategy for Relieving Inflammatory Diseases. Targeting TNF-alpha examines the immunotherapeutic approach for alleviating neuropathic pain. The key role of immunomodulatory cytokines for the development of novel nk cell-based cancer therapies focuses on the importance of cytokines in developing new cancer treatments. Finally, complexities in the clinical development of TGFβ inhibitors covers the challenges in creating inhibitors for TGFβ.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Is the book original?

All books in our catalog are Original.

In what language is the book written?

The book is written in English.

What is the format of this book?

The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews